The Role of Abdominal CT Scan as Follow‐up after Complete Remission with Successful Helicobacter pylori Eradication in Patients with H. pylori‐Positive Stage IE1 Gastric MALT Lymphoma

Background:  Eradication of Helicobacter pylori with antibiotics is the established initial treatment of patients with localized gastric mucosa‐associated lymphoid tissue (MALT) lymphoma. However, there are few reports on follow‐up modalities to identify sustained remission in patients who achieve complete remission (CR). We therefore investigated the role of abdominal computed tomography (CT) as follow‐up after CR with H. pylori eradication.

[1]  Harlan M Krumholz,et al.  Exposure to low-dose ionizing radiation from medical imaging procedures. , 2009, The New England journal of medicine.

[2]  F. Cavalli,et al.  Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Hsiu‐Po Wang,et al.  Long-term Follow-up of Gastrectomized Patients With Mucosa-associated Lymphoid Tissue Lymphoma: Need for a Revisit of Surgical Treatment , 2008, Annals of surgery.

[4]  M. Seto,et al.  Clinical Features and Prognosis of Gastric MALT Lymphoma With Special Reference to Responsiveness to H. pylori Eradication and API2-MALT1 Status , 2008, The American Journal of Gastroenterology.

[5]  M. Raderer,et al.  Therapy of gastric mucosa-associated lymphoid tissue lymphoma , 2007, Expert opinion on pharmacotherapy.

[6]  H. Seno,et al.  Rapid Development of Diffuse Large B-Cell Lymphoma After Successful Eradication of Helicobacter pylori for Gastric MALT Lymphoma , 2006, American Journal of Gastroenterology.

[7]  G. Lee,et al.  A Prospective Analysis of Low‐Grade Gastric MALT Lymphoma after Helicobacter pylori Eradication , 2006, Helicobacter.

[8]  M. Du,et al.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management , 2006, Gut.

[9]  M. Stolte,et al.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Matsumoto,et al.  Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment , 2005, Cancer.

[11]  R. Gascoyne,et al.  Helicobacter pylori and MALT lymphoma. , 2005, Gastroenterology.

[12]  C. Suh,et al.  Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. , 2004, World journal of gastroenterology.

[13]  M. Stolte,et al.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.

[14]  J. Benhattar,et al.  The natural history of a gastric low grade B cell MALT lymphoma followed during 11 years without treatment. , 2002, Journal of clinical pathology.

[15]  C. Copie-Bergman,et al.  Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome , 2001, American Journal of Gastroenterology.

[16]  T. Molina,et al.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pyloritreatment , 2001, Gut.

[17]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[18]  P. Isaacson,et al.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori , 1993, The Lancet.

[19]  T. Radaszkiewicz,et al.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. , 1992, Gastroenterology.

[20]  E. Zucca,et al.  Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  R. Greil,et al.  Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters. , 2001, Pathology, research and practice.

[22]  P. Isaacson,et al.  Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. , 1993, The American journal of pathology.